Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Northeastern University
- New England HERC
- University of North Carolina at Chapel Hill
- Yale School of Medicine - Department of Genetics
- Cornell University
- George Washington University
- Queen Mary University of London
- Stanford University
- The Jiang Lab, The Icahn School of Medicine at Mount Sinai
- University of California, Los Angeles
- University of Copenhagen
- University of Kansas Medical Center
- 2 more »
- « less
-
Field
-
/Regular A Research Scientist/Postdoctoral fellow position is available in the laboratory of Dr. Giovanni Ligresti to study basic and translational aspects of lung fibrosis with specific emphasis on
-
University of California, Los Angeles | Los Angeles, California | United States | about 16 hours ago
samples for the discovery of pathways that lead to fibrosis, emphysema, or granulomas. Our research program focuses on lung transplant with the goal of inducing murine tolerance via hematopoietic mixed
-
as possible thereafter. The project Cardiac fibrosis is a major driver of heart failure and a common endpoint of many forms of cardiac injury and disease. This project will use zebrafish as a model
-
research focused on cystic fibrosis-related diabetes to improve understanding of disease mechanisms and identify approaches to prevent and treat cystic fibrosis-related diabetes. This role provides
-
how strain-induced tissue electrical polarisation influence cell–matrix interactions during lung fibrosis progression. The postholder will develop bioelectronic in vitro platforms to precisely
-
company that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions. The company has approved therapies for cystic fibrosis, sickle cell disease
-
create transformative medicines for people with serious diseases and conditions. The company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and
-
company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas
-
diseases and conditions. The company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and
-
Yale School of Medicine - Department of Genetics | New Haven, Connecticut | United States | 26 days ago
scales), plus full Yale benefits Closing date 26 Nov 2026 Website https://www.chiocciolilab.com/ View more categories View less categories Discipline Applied Science , Biomedicine , Clinical